Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 2

2(33.3%)

Phase 3

1(16.7%)

6Total

N/A(3)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01051895Not ApplicableActive Not Recruiting

Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers

Role: collaborator

NCT04995185Not ApplicableCompleted

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

Role: collaborator

NCT00110110Phase 2Active Not Recruiting

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

Role: collaborator

NCT05827458Completed

An Adequate Cost Effective Follow Up Protocol For Bone and Soft Tissue Sarcomas

Role: collaborator

NCT00384735Completed

An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial

Role: lead

NCT03429972Phase 2Unknown

Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients

Role: collaborator

NCT02680613Not ApplicableCompleted

Pilot Study of a Mobile Health Approach to Reduce Barriers to Cervical Cancer Screening in Tanzania

Role: collaborator

NCT00517959Phase 3Unknown

SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors

Role: collaborator

All 8 trials loaded